https://www.medera.bio/medera-biopharm-s-sardocor-showcases-positive-interim-data-from-heref-gene-therapy-phase-1/medera-strengthens-leadership-team-with-three-key-executives 1.0 monthly 2025-09-30 https://www.medera.bio/contact-us 1.0 monthly 2025-08-21 https://www.medera.bio/medera-biopharm-s-sardocor-showcases-positive-interim-data-from-heref-gene-therapy-phase-1/medera-s-novoheart-enters-new-collaboration-to-develop-human-mini-heart-models 1.0 monthly 2025-08-21 https://www.medera.bio/overview 1.0 monthly 2025-08-21 https://www.medera.bio/medera-biopharm-s-sardocor-showcases-positive-interim-data-from-heref-gene-therapy-phase-1/medera-s-novoheart-releases-latest-cardiac-screening-innovation-ctscreen-v1-5 1.0 monthly 2025-08-21 https://www.medera.bio/dr-barry-borlaug--md 1.0 monthly 2025-08-21 https://www.medera.bio/medera-biopharm-s-sardocor-showcases-positive-interim-data-from-heref-gene-therapy-phase-1/heart-in-a-jar---singapore-to-bioengineer-asian-mini-models-of-failed-hearts-to-test-drugs 1.0 monthly 2025-08-21 https://www.medera.bio/ronald-li 1.0 monthly 2025-08-21 https://www.medera.bio/dr-dongsheng-duan--phd 1.0 monthly 2025-08-21 https://www.medera.bio/mary-liberio 1.0 monthly 2025-08-21 https://www.medera.bio/andrew-lau 1.0 monthly 2025-08-27 https://www.medera.bio/medera-receives-fda-clearance-for-a-first-in-human-gene-therapy-trial-for-heart-failure 1.0 monthly 2025-08-21 https://www.medera.bio/management-ii 1.0 monthly 2025-12-15 https://www.medera.bio/deborah-k-lieu--phd 1.0 monthly 2025-08-21 https://www.medera.bio/dr-michael-taylor--md--phd 1.0 monthly 2025-12-15 https://www.medera.bio/dr-hesham-a-sadek--m-d---ph-d 1.0 monthly 2025-08-21 https://www.medera.bio/news 1.0 monthly 2026-01-05 https://www.medera.bio/dr-sven-henrichwark 1.0 monthly 2025-08-21 https://www.medera.bio/medera-biopharm-s-sardocor-showcases-positive-interim-data-from-heref-gene-therapy-phase-1/medera-completes-patient-dosing-in-phase-1/2a-music-hfref-trial-of-srd-001-gene-therapy-for-heart-failure 1.0 monthly 2025-08-21 https://www.medera.bio/medera-biopharm-s-sardocor-showcases-positive-interim-data-from-heref-gene-therapy-phase-1/medera-announces-publication-of-study-utilizing-machine-learning-to-enhance-next-generation-drug-screening-with-human-mini-heart-technology 1.0 monthly 2025-08-21 https://www.medera.bio/medera-biopharm-s-sardocor-showcases-positive-interim-data-from-heref-gene-therapy-phase-1/medera-to-present-late-breaking-phase-1 1.0 monthly 2025-08-21 https://www.medera.bio/pat-furlong--ms--bsn 1.0 monthly 2025-08-21 https://www.medera.bio/novoheart-named-2020-venture-50-company 1.0 monthly 2025-08-21 https://www.medera.bio/roger-hajjar 1.0 monthly 2025-08-21 https://www.medera.bio/medera-biopharm-s-sardocor-showcases-positive-interim-data-from-heref-gene-therapy-phase-1/2-clinical-trial-in-late-breaking-oral 1.0 monthly 2025-08-21 https://www.medera.bio/medera-biopharm-s-sardocor-showcases-positive-interim-data-from-heref-gene-therapy-phase-1/medera-and-singapore-s-cardiovascular-disease-national-collaborative-enterprise-launch-asia-s-first-cardiac-gene-therapy-trial-for-heart-failure 1.0 monthly 2025-08-21 https://www.medera.bio/medera-s-sardocor-granted-fda-orphan-drug-designation 1.0 monthly 2025-08-21 https://www.medera.bio/medera-biopharm-s-sardocor-showcases-positive-interim-data-from-heref-gene-therapy-phase-1/medera-novoheart-expands-human-cardiac-research-with-ctscreen-installation 1.0 monthly 2025-08-21 https://www.medera.bio/isuru-karunaratne 1.0 monthly 2025-08-21 https://www.medera.bio 1.0 monthly 2025-08-21 https://www.medera.bio/medera-s-sardocor-announces-fda-clearance-of-ind-for-first-in-human-gene-therapy-clinical-trial-for-dmd 1.0 monthly 2025-08-21 https://www.medera.bio/heart-in-a-jar-platform-humanizing-preclinical-research 1.0 monthly 2025-08-21 https://www.medera.bio/allen-ma 1.0 monthly 2025-08-21 https://www.medera.bio/3d-printed-mini-organs-may-provide-safe-testing-of-covid-19-therapies 1.0 monthly 2025-08-21 https://www.medera.bio/preeti-ashok--phd 1.0 monthly 2025-08-27 https://www.medera.bio/james-topham 1.0 monthly 2025-08-21 https://www.medera.bio/dr-brian-jaski--md 1.0 monthly 2025-08-21 https://www.medera.bio/medera-s-sardocor-announces-fast-track-designation 1.0 monthly 2025-08-21 https://www.medera.bio/sandra-morgan 1.0 monthly 2025-08-21 https://www.medera.bio/medera-biopharm-s-sardocor-showcases-positive-interim-data-from-heref-gene-therapy-phase-1/medera-to-present-late-breaking-phase-1/2a-clinical-trial-results-at-heart-failure-2025-congress 1.0 monthly 2025-08-21 https://www.medera.bio/kevin-costa 1.0 monthly 2025-08-21 https://www.medera.bio/medera-biopharm-s-sardocor-showcases-positive-interim-data-from-heref-gene-therapy-phase-1/medera-inc-to-be-listed-on-nasdaq-through-a-merger-agreement-with-keen-vision-acquisition-corporation 1.0 monthly 2025-08-21 https://www.medera.bio/suresh-pullela 1.0 monthly 2025-08-21 https://www.medera.bio/jeff-rudy 1.0 monthly 2025-08-21 https://www.medera.bio/shiva-singh 1.0 monthly 2025-08-21 https://www.medera.bio/medera-biopharm-s-sardocor-showcases-positive-interim-data-from-heref-gene-therapy-phase-1/medera-to-participate-in-two-upcoming-investor-conferences 1.0 monthly 2025-08-21 https://www.medera.bio/michelle-khine 1.0 monthly 2025-08-21 https://www.medera.bio/medera-biopharm-s-sardocor-showcases-positive-interim-data-from-heref-gene-therapy-phase-1/medera-completes-patient-dosing-in-phase-1/medera-receives-dsmb-clearance-to-initiate-phase-2-portion-of-music-hfref-phase-1b/2-trial 1.0 monthly 2025-08-21 https://www.medera.bio/medera-biopharm-s-sardocor-showcases-positive-interim-data-from-heref-gene-therapy-phase-1/updated-results-first-in-human-gene-therapy-trial-for-heart-failureb19ebbea 1.0 monthly 2025-08-21 https://www.medera.bio/medera-s-novoheart-partners-with-astrazeneca 1.0 monthly 2025-08-21 https://www.medera.bio/about-us 1.0 monthly 2025-08-21 https://www.medera.bio/sue-kim--mba 1.0 monthly 2025-08-21 https://www.medera.bio/mark-mercola 1.0 monthly 2025-08-21 https://www.medera.bio/dr-pradeep-mammen-m-d 1.0 monthly 2025-08-21 https://www.medera.bio/erin-roberts 1.0 monthly 2025-08-21 https://www.medera.bio/our-pipeline 1.0 monthly 2025-08-21 https://www.medera.bio/medera-biopharm-s-sardocor-showcases-positive-interim-data-from-heref-gene-therapy-phase-1/medera-to-present-late-breaking-phase-1/medera-showcased-positive-interim-data-from-first-in-human-gene-therapy-trial 1.0 monthly 2025-08-21 https://www.medera.bio/michael-taylor 1.0 monthly 2025-08-21 https://www.medera.bio/medera-biopharm-s-sardocor-showcases-positive-interim-data-from-heref-gene-therapy-phase-1/medera-and-university-of-kansas-medical-center-announce-pioneering-gene-therapy-trial 1.0 monthly 2025-08-21 https://www.medera.bio/medera-biopharm-s-sardocor-showcases-positive-interim-data-from-heref-gene-therapy-phase-1/medera-s-novoheart-and-curi-bio-partner-to-transform-human-based-cardiac-drug-screening 1.0 monthly 2025-08-21 https://www.medera.bio/james-kim 1.0 monthly 2025-08-28 https://www.medera.bio/medera-biopharm-s-sardocor-showcases-positive-interim-data-from-heref-gene-therapy-phase-1/medera-announces-completion-of-cohort-a-and-initiation-of-dosing-in-cohort-b-of-music-hfpef 1.0 monthly 2025-08-21 https://www.medera.bio/medera-biopharm-s-sardocor-showcases-positive-interim-data-from-heref-gene-therapy-phase-1/medera-announces-first-patient-dosed-in-phase-2-portion-of-music-hfref-phase-trial 1.0 monthly 2025-10-27 https://www.medera.bio/niharika-kamat 1.0 monthly 2025-09-15 https://www.medera.bio/fubao-wang 1.0 monthly 2025-09-15 https://www.medera.bio/medera-biopharm-s-sardocor-showcases-positive-interim-data-from-heref-gene-therapy-phase-1/medera-presents-late-breaking-data-from-first-in-human-gene-therapy-trial 1.0 monthly 2025-11-09 https://www.medera.bio/medera-biopharm-s-sardocor-showcases-positive-interim-data-from-heref-gene-therapy-phase-1/medera-to-participate-in-oppenheimer-movers-in-rare-disease-summit-2025 1.0 monthly 2025-12-04 https://www.medera.bio/medera-biopharm-s-sardocor-showcases-positive-interim-data-from-heref-gene-therapy-phase-1/medera-announces-completion-of-patient-enrollment-in-cohort-b-of-music-hfpef-phase-1/2a-clinical-trial 1.0 monthly 2026-01-05